Polaroid Therapeutics
Polaroid Therapeutics is a Swiss-based biotech start-up, established in 2022 and incubated by the iconic Polaroid brand. The company is dedicated to addressing major challenges in antimicrobial therapies through cutting-edge technology and research. Its mission is to create a more human, meaningful, and healthier world by developing proprietary antimicrobial polymer technologies that reduce bioburden, improve patient outcomes, and do not trigger antimicrobial resistance (AMR). Polaroid Therapeutics focuses on advanced wound care, medical device coatings, and holistic therapeutic applications, aiming to set new standards in patient-centric care and global health.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Antimicrobial polymer technology platform for wound care and device coatings
A polymer-based antimicrobial platform designed to be incorporated into wound dressings and device coatings to reduce bacterial bioburden with sustained activity while avoiding induction of antimicrobial resistance.
Prototype advanced wound dressings (CMC gelling fibre prototypes)
Prototype dressings combining antimicrobial polymers with carboxymethyl cellulose gelling fibres designed for cavity and complex wound management.
Antimicrobial polymer technology platform for wound care and device coatings
A polymer-based antimicrobial platform designed to be incorporated into wound dressings and device coatings to reduce bacterial bioburden with sustained activity while avoiding induction of antimicrobial resistance.
Prototype advanced wound dressings (CMC gelling fibre prototypes)
Prototype dressings combining antimicrobial polymers with carboxymethyl cellulose gelling fibres designed for cavity and complex wound management.
Expertise Areas
- Antimicrobial polymer development
- Advanced wound care product development
- Medical device coating technologies
- Preclinical and translational research
Key Technologies
- Quaternized cationic antimicrobial polymers
- Carboxymethyl cellulose (CMC) gelling fibres
- Device surface antimicrobial coatings
- 3D printing for medical devices/dressings
Key People
News & Updates
Achievement of significant pre-clinical milestones in developing innovative medical devices using proprietary polymer technology that reduces bacterial bioburden without triggering antimicrobial resistance.
CEO Ran Frenkel discusses the company's vision to redefine healing, focusing on prevention, patient empowerment, and open-source collaboration to combat antimicrobial resistance and improve chronic wound care.
Announcement of Dr. Markus Rothmaier's appointment as Head of R&D, highlighting his role in advancing antibacterial technologies and product development.
Polaroid Therapeutics and The University of Hull have partnered to launch the world’s first £48M international Wound Innovation Centre (WIC), bringing together multidisciplinary experts to address critical issues in wound care and antimicrobial resistance.
Polaroid Therapeutics and SFM Limited are collaborating to develop a novel wound dressing that prevents infection and aids healing, leveraging proprietary antimicrobial polymer technology and advanced fibre technology.
Polaroid Therapeutics partners with Ingenix.AI to embed multimodal and multiscale agentic AI into clinical workflows, aiming to accelerate advanced patient-centred therapies and improve clinical trial outcomes.
Achievement of significant pre-clinical milestones in developing innovative medical devices using proprietary polymer technology that reduces bacterial bioburden without triggering antimicrobial resistance.
CEO Ran Frenkel discusses the company's vision to redefine healing, focusing on prevention, patient empowerment, and open-source collaboration to combat antimicrobial resistance and improve chronic wound care.
Announcement of Dr. Markus Rothmaier's appointment as Head of R&D, highlighting his role in advancing antibacterial technologies and product development.
Polaroid Therapeutics and The University of Hull have partnered to launch the world’s first £48M international Wound Innovation Centre (WIC), bringing together multidisciplinary experts to address critical issues in wound care and antimicrobial resistance.
Polaroid Therapeutics and SFM Limited are collaborating to develop a novel wound dressing that prevents infection and aids healing, leveraging proprietary antimicrobial polymer technology and advanced fibre technology.
Polaroid Therapeutics partners with Ingenix.AI to embed multimodal and multiscale agentic AI into clinical workflows, aiming to accelerate advanced patient-centred therapies and improve clinical trial outcomes.